Thymoquinone Ameliorates Acute Kidney Injury Induced by Renal Ischemia-Reperfusion

Tweet about this on TwitterShare on FacebookEmail this to someoneShare on Google+

Hend Ashour; Laila Rashed; Miran Atif Elkordy & Omaima Mohammed Abdelwahed


Renal ischemia-reperfusion injury (IRI)is an unavoidable consequence in renal transplantation and multiple clinical settings. A debate has been raised about the particular role of hypoxia-inducible factor (HF-1α) in the renal injury pathogenesis and the renal cortex ultrastructural alterations. Also, we investigated the antioxidant/anti-inflammatory effect of thymoquinone and its modulatory role on HIF-1α in protection against renal IRI.Adult male Wister albino rats were assigned into 3 groups (n=16); 1) Sham-operated, 2) IRI model and 3) renal IRI pre-treated with thymoquinone 10 (TQ-IRI) for 10 days and at the reperfusion onset. Following the operation, 8 rats from each group were euthanized after 3 hours and the remaining 8 rats at 24 hours. Renal injury was assessed by the increased blood urea nitrogen, creatinine level, and the EGTI histological injury scoreat both 3 and 24h. HIF-1α was upregulated (p<0.01) and was correlated with renal tissue reactive oxygen species (ROS) production and total oxidant capacity (TAC) consumption. Elevated inflammatory markers (NFkB, MCP-1 and VCAM-1) were associated with renal IRI.Thymoquinone treatment inhibited the accumulation of HIF-1α (p<0.01), reduced renal oxidation/inflammation process and markedly diminished renal injury.

KEY WORDS: Ischemia-reperfusion injury; Renal; HIF-1a; Thymoquinone.

How to cite this article

ASHOUR, H.; RASHED, L.; ELKORDY, M. A. & ABDELWAHED, O. M. Thymoquinone ameliorates acute kidney injury induced by renal ischemia-reperfusion. Int. J. Morphol., 39(2):469-476, 2021.